Wishbone SA
6.0 FTEThe score of Wishbone shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +44 % Total assets +28 % Headcount (avg FTE) +5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wishbone's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 04 Nov 2025
- Year ended 31 Dec 2023filed on 06 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 21 Jun 2022
Wishbone's financial analysis
- Solvency52.1%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wishbone
Wishbone's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0543.516.635
- VAT number
- BE0543516635
- Peppol
- Registered · 0208:0543516635 · as of 09 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Dec 2013
- Registered office
- 4400 Flémalle
- Size
- Micro · 6.0 FTE
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Wishbone (SA) has been based in Flémalle since 2013, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of €1.22m and equity of €1.77m; its revenue is not published. With 6.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 52.1%, below the median of its sector (57.9%).
Companies similar to Wishbone
Companies in the same business, of comparable size and area, outside its group.
- XomeXBio Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.50m
- Genflow Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.74m
- ExeVir Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.76m
- Tanai Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.87m
- Ipratech Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.29m
- Olfadog Biotech Research and experimental development on natural sciences and engineering Waterloo · balance sheet €1.80m
- BIO-Sourcing Research and experimental development on natural sciences and engineering Liège · balance sheet €6.59m
- Amyl Therapeutics Research and experimental development on natural sciences and engineering Liège · balance sheet €7.02m
Frequently asked questions about Wishbone
What is the revenue of Wishbone?
Wishbone files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wishbone?
In Belgium, the VAT number is the company number prefixed with BE: BE0543516635 for Wishbone, if the company is VAT-registered. Its company number (CBE) is 0543.516.635.
Where is the registered office of Wishbone?
According to the CBE register, the registered office of Wishbone is in 4400 Flémalle.
What is the equity of Wishbone?
At the close of the 2025 financial year, the equity of Wishbone amounts to 1,766,378 €, a solvency of 52.1% of total assets.
How many people work at Wishbone?
6.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Wishbone?
The register lists 10 active mandates at Wishbone. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wishbone
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →